GlassScriptPhysician profile
Jennifer Drummond
NPI 1821658709
$580.33
in general payments reported to CMS, 2019-2025
9 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $77.62 · 2021: $52.78 · 2022: $28.64 · 2023: $85.50 · 2024: $188 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $421.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $421.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $159.04 | 2020-2022 | |
| Pfizer INC. | $132.08 | 2023-2024 | |
| Zoll Circulation INC | $81.92 | 2025 | Therox Ds2 Console, Downstream Cartridge, Catheter |
| Cardiva Medical, INC. | $57.66 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $47.09 | 2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.33 | 2024 | |
| Chiesi USA, INC. | $25.88 | 2024 | Cleviprex |
| Alnylam Pharmaceuticals INC. | $24.12 | 2024 | Amvuttra |
| Abbott Laboratories | $19.21 | 2025 | Gallant |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Drummond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.